United States · FDA National Drug Code directory
STAHIST AD
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58407-625_4041d3f9-d1cb-0931-e063-6394a90a82de
- Product NDC
- 58407-625
- Form
- TABLET
- Composition / generic term
- CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE
- Labeler
- Magna Pharmaceuticals, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20111220
- Source listing expiry
- 20261231
Source-listed ingredients
- CHLORCYCLIZINE HYDROCHLORIDE — 25 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TABLET in 1 BLISTER PACK (58407-625-01) · 58407-625-01
- 6 BLISTER PACK in 1 BOX (58407-625-06) / 1 TABLET in 1 BLISTER PACK (58407-625-01) · 58407-625-06
- 1 BOTTLE in 1 BOX (58407-625-30) / 30 TABLET in 1 BOTTLE · 58407-625-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →